About AGGX

About

AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

Advertisement|Remove ads.